SUBSCRIBE
Wed, Jun 29, 2022
Health For Mzansi
  • Trending
  • My Health
  • Conversations
    • Podcast
  • Grow It
  • Recipes
  • Choices
No Result
View All Result
  • Trending
  • My Health
  • Conversations
    • Podcast
  • Grow It
  • Recipes
  • Choices
No Result
View All Result
Health For Mzansi
No Result
View All Result

EpiPens: Mzansi can’t access this lifesaving allergy treatment

by Elna Schütz
23rd Feb 2022
in Trending
Reading Time: 8 mins read
A A
EpiPens: Mzansi can’t access this lifesaving allergy treatment

Epinephrine auto-injectors, often known by the commercial name EpiPen, can be life-savers for people suffering severe allergic reactions, but the treatments are difficult to find in South Africa and expensive. Photo: Flickr

Share on FacebookShare on TwitterShare on Whatsapp

Epinephrine auto-injectors, often known by the commercial name EpiPen, can be life-savers for people suffering severe allergic reactions, but the treatments are difficult to find in South Africa and expensive. 

Mariaan Schoeman was recently away from her Johannesburg home when she was stung by a bee and struggled to breathe. She received emergency assistance for the unexpected allergic reaction, but when she tried to find an autoinjector for possible future attacks, it took her weeks and visits to multiple pharmacies in several cities to locate one.

Allergy specialist, Dr Marinda Mcdonald. Photo: Allergy Doc

“I just don’t understand why it is so hard to find,” she says. “So many people told me they just gave up. All of these people could potentially die.”

ADVERTISEMENT

Esti Linder from George has faced similar challenges. She has gotten used to checking each pharmacy she goes to for the potentially life-saving product for her five-year-old son. She says she has not bought one in several years because the devices she has found either have short shelf lives or are not available in a dosage appropriate for children.

“Beyond the problem of availability is the additional issue with cost. It is expensive,” Linder says. “For such a lifesaving tool, to not be able to find any or afford any is absolutely ridiculous.”

ADVERTISEMENT

A lifesaver

While allergic reactions differ in severity and form and might respond to antihistamines or other medicines, adrenaline in the form of an epinephrine auto-injector is one of the best first-line treatments for severe allergic reactions (anaphylaxis).

In South Africa, it is a schedule 4 medicine, meaning that it must be prescribed by a healthcare practitioner, including emergency care providers. It cannot be dispensed over the counter without a prescription.

Ahmed Bayat, COO of the Independent Community Pharmacy Association (ICPA), explains that while the exact number of people who require this treatment in South Africa is unclear, the demand from those who do need it is high.

Yuven Gounden, spokesperson for the South African Health Products Regulatory Authority (SAHPRA), confirms that the only two epinephrine auto-injector products approved as medicines in South Africa are the Mylan EpiPen, registered in 1993, and Mylan’s EpiPen Junior, registered in 2006.

ADVERTISEMENT

While epinephrine is the first-line treatment for anaphylaxis, there are several other treatments registered that are supportive, such as oxygen and beta-agonists, to help patients breathe. SAHPRA is also currently processing three cortisone products, which are supportive therapy to control abnormal immune responses after an anaphylactic episode is resolved.

Khadija Jamaloodien, the Director of Affordable Medicines at the National Department of Health, confirms that there are contracts for adult and junior epinephrine auto-pens, running until April 2024. “At present, we are not experiencing supply constraints for these items,” she says.

A company spokesperson for Viatris (Mylan is part of Viatris) told Spotlight that they take distribution of the auto-injectors very seriously and continuously monitor supply and demand in the country.

“We currently have stock of EpiPen and EpiPen Jr Auto-Injectors in the market,” the spokesperson said.

“Due to the dynamic nature of demand, there may be temporary supply constraints of stock at times.”

The company also says that they engage with various stakeholders, such as government and manufacturers, to minimise supply disruptions.

Availability issues

Doctors in both the public and private sector, however, indicate that not being able to find auto-injectors is a regular, ongoing problem for people in South Africa.

Bayat says, “I know that there have been periods when there were shortages and they were in short supply across the whole supply chain from manufacturer to distributors and wholesalers and then finally to pharmacies.” He suspects that the problems are partly logistical around the length and difficulty of the importation process.

Professor Debbie White, Paediatric Pulmonologist at Charlotte Maxeke Johannesburg Academic Hospital, says she has not been able to access the pens, despite efforts to make them available.

Dr Marinda McDonald, a GP specialising in allergies in Johannesburg, says the vast majority of her patients have been able to access the pens, but that this may be because of her particular clientele and her efforts in finding stock. McDonald calls the supply erratic and completely inconsistent, often coming down to luck. “Mylan is not forthcoming with help or support at all,” she says and suspects that the country receives the product in irregular batches instead of a rolling supply.

“There’s always a point where we can only get EpiPens that are three months expired.”

She says that while larger pharmacy chains are dependent on certain distributors, smaller providers can sometimes find the product through smaller distributors.

Professor Michael Levin, head of the paediatric allergy division at Red Cross Children’s Hospital and CEO of the Allergy Foundation of South Africa, says that while he does have access and distributes the pens regularly, he knows his clinic is unusual in this regard.

Expensive and fragile

The difficulties in finding these products stocked in pharmacies are further exacerbated by the prices and expiration dates.

The Master Health Product List of 2022 quotes an EpiPen at around R740, with Bayat saying a pharmacy can charge a maximum of around R1 157. If patients are members of a medical aid, their devices may be covered as a prescribed minimum benefit, meaning that the costs are covered out of the risk portion of the plan. Mylan made headlines in the United States in 2016 when they hiked the price of the EpiPen – but South Africa has been shielded from similarly dramatic price hikes since medicines price increases here are strictly regulated.

Even so, White says that EpiPen prices are “extremely expensive and unaffordable for most of our patients”. She also notes that most patients ideally require several products, for instance, one at home and one at work or with a secondary caregiver.

Professor Mike Levin from the Allergy Foundation of South Africa. Photo: Western Cape Government

Currently, only double-pack Epipens are available in the country, which fulfills this need but increases the price. The double-pack does also at times come with a ‘trainer’, which is a dummy device that can be used to teach others how to use it.

McDonald says, “What I can say is the fact that there’s only a sole supplier and one product in the country does reduce the imperative of the company to compete in a cost-effective manner.”

If patients do find Epipens, which ideally are not used regularly, the products might expire in four or five months and then have to be returned to a pharmacy to be discarded safely. “Adrenaline by nature is very fragile,” Bayat says, explaining that it is sensitive to both light and temperature.

One form of relief that has been implemented is a Stock Protection Letter, which is given if the Epipen has less than 11 months to its expiration date and means that it can be replaced at no cost to the patient. The letter is meant to be issued to the pharmacy or doctor by Mylan, though several of the experts Spotlight spoke to said they had not experienced this process being fully completed yet.

Alternatives

While the Epipen product is arguably the international leader in this field, there are a few alternatives, such as the Anapen, which McDonald says has been in the country in the past.

Local startup Impulse Biomed has a reloadable device in development that would allow for the needle and casing to be reused if the epinephrine has expired before being used, making the device cheaper. While there is no definite date yet for their product, called the ZiBiPen, to go to market, media coverage around a recent investment into the company projects a possible launch in 2023.

Levin was involved with the original idea and explains that the first iterations were meant to include variable doses and needle lengths depending on the particular patient, but that this was quite difficult to achieve technically.

White explains that at Charlotte Maxeke Hospital, they give patients emergency kits, which contain a vial of adrenaline and a syringe with a clearly written action plan on when and how to use it in the correct dose.

“It is obviously harder to administer than an EpiPen and requires good caregiver education but serves as a valuable and more affordable alternative,” says White.

This option, while difficult and potentially dangerous, is often the best one at hand, and is dramatically cheaper than an EpiPen. Where possible, practitioners ease the process by pre-filling a syringe.

Future steps  

While some of those who need this lifesaving product have found ways to protect themselves, the situation is clearly far from ideal.

“Ideally another product on the market would be great as this would hopefully bring the price down and make this lifesaving medication more affordable to all,” says White.

“I would like to see a substantial improvement in the availability and the longevity of the devices,” says Levin, “whether that’s through improved distribution with Mylan with existing products, or whether it’s through the registration of additional products in the country.”

McDonald also calls for greater additional training of healthcare professionals around allergies. “If we have a scarce resource, then you shouldn’t prescribe an EpiPen if there’s not an indication for it. It’s not a security blanket.”

Furthermore, Levin says, “I would like an exception to be made with SAHPRA for the need for named patient basis for the prescription of adrenaline auto-injectors to allow schools and other places where people at risk are likely to congregate, to be able to have undesignated EpiPens.”

This article was first published on Spotlight – In depth public interest health journalism.

Tags: allergic reactionallergiesfood allergyPublic healthSAHPRA
Share130Tweet81Send
Previous Post

Water: how much should I drink every day?

Next Post

Riky Rick dies: 7 tips to boost your mental health

Elna Schütz

Elna Schütz

Related Articles

When is a disease deemed a global emergency?
Trending

When is a disease deemed a global emergency?

by The Conversation
29th Jun 2022
0

The world has come a long way since the outbreak of cholera in the mid-1900s, and so too have the International Health Regulations. When there is a disease outbreak, a number of...

Read more
Monkeypox: Disease experts give the true facts

Monkeypox: Disease experts give the true facts

28th Jun 2022
Tavern tragedy: Teen issues under the microscope

Tavern tragedy: Teen issues under the microscope

28th Jun 2022
Dance therapy: Dance and movement therapy offers a self-empowering mind-body approach to mental health treatment. Photo: Supplied/Health For Mzansi

Dancing can help your brain, so get your groove on!

27th Jun 2022
Next Post
Tributes continue to pour following the news of award-winning rapper, Rikhado 'Riky Rick' Muziwendlovu Makhado. Photo: Instagram/Riky Rick

Riky Rick dies: 7 tips to boost your mental health

Nurses make up the largest group of healthcare providers in South Africa. The performance of any healthcare system is directly dependent on the quality of care afforded by these healthcare professionals. Photo: Supplied/Health For Mzansi

Underpaid and gatvol: Healthcare workers speak out

Burnout: No, smacking your colleagues  isn’t an option

Burnout: No, smacking your colleagues isn’t an option

Stories

Finding a happy medium: Divorce vs co-parenting
Loyiso taps into liquid gold of extra virgin olive oil
Youth transform dumping site into thriving food garden
Winter: An ideal time to plant root veggies, take stock
Early pregnancy care essential for moms-to-be
Meet Mzansi’s Keto Queen, Sharney Blackway
Heart health: Keep your diet lean, clean and green
Yummy Meatless Wellington
No Result
View All Result

Categories

  • Choices (40)
  • Conversations (74)
  • Featured (1)
  • Grow It (52)
  • My Health (103)
  • Podcast (43)
  • Recipes (56)
  • Remedies (5)
  • Trending (274)

Recent

Olive vs vegetable oil: Soak up the best of both worlds

Olive vs vegetable oil: Soak up the best of both worlds

29th Jun 2022
When is a disease deemed a global emergency?

When is a disease deemed a global emergency?

29th Jun 2022
Boost your iron levels with Mangale’s pap and spinach

Boost your iron levels with Mangale’s pap and spinach

28th Jun 2022
Health For Mzansi

Contact us
Office: +27 21 879 1824

Marketing: +27 71 147 0388
News: hello@healthformzansi.co.za
Advertising: sales@foodformzansi.co.za

Privacy Policy
Cookie Policy

cropped-Katlego-Moloto.png

Weight loss a health triumph for determined mom

cropped-Untitled-design-6.jpg

Early pregnancy care essential for moms-to-be

cropped-poster-2022-06-06T090553.304.jpg

Youth transform dumping site into thriving food garden

Olive vs vegetable oil: Soak up the best of both worlds

When is a disease deemed a global emergency?

Boost your iron levels with Mangale’s pap and spinach

Monkeypox: Disease experts give the true facts

Tavern tragedy: Teen issues under the microscope

Dancing can help your brain, so get your groove on!

No Result
View All Result
  • Trending
  • My Health
  • Conversations
    • Podcast
  • Grow It
  • Recipes
  • Choices

© 2021 Health For Mzansi | Farmers For Change Pty (Ltd)

By continuing the use of our Website, you are explicitly and actively consenting to our processing of your personal information as per our Privacy Policy.
Cookie SettingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Go to mobile version
Finding a happy medium: Divorce vs co-parenting Loyiso taps into liquid gold of extra virgin olive oil Youth transform dumping site into thriving food garden Winter: An ideal time to plant root veggies, take stock Early pregnancy care essential for moms-to-be Meet Mzansi’s Keto Queen, Sharney Blackway Heart health: Keep your diet lean, clean and green Yummy Meatless Wellington